Triclosan
Active ingredient · 2 therapeutic classes
Sold as Keystone · TRICLOSEPTIC · EcoCare 250 · BACTI-STAT AE · ZEROLATUM PLUS
- Drug class
- Phenol and Derivatives
- Availability
- Over-the-counter
- Routes
- Topical, Topical (Household)
- Markets covered
- 3
- Products on record
- 14
- FDA reports (12 mo)
- 131
Overview
Triclosan is an active pharmaceutical ingredient in the Phenol and Derivatives group (D08AE). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 2 | March 21, 2024 |
| GB United Kingdom | MHRA | 2 | December 19, 2025 |
| CA Canada | Health Canada | 10 | March 22, 2025 |
USUnited States· FDA
2 products
Uses
Uses for handwashing to decrease bacteria on the skin
How to take
GBUnited Kingdom· MHRA
2 products
Uses
ATC Code:
DO2A For the prophylactic treatment of eczemas at risk from infection.
How to take
CACanada· Health Canada
10 products
10 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [3].
Sources & citations
- [1]FDA DailyMed · 0e7ccbbe-0cda-4d… · revised March 18, 2024 [PDF]
- [2]MHRA (UK) · PL002400426 · revised July 25, 2025
- [3]Health Canada (DPD) · 00266507 · revised March 22, 2025
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.